Injecting regulatory T cells or Tregs, which control the body’s immune responses, directly into damaged bone, muscle and skin significantly boosts healing, according to new research. The door is now ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...
For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...
Traditionally, Tregs were thought to be specialist cell populations found only in specific areas of the body. However, a new study by scientists from the University of Cambridge in the UK has ...
Lower regulatory T cells (Tregs) at diagnosis in patients with multiple myeloma were linked to early relapse and may indicate functional high-risk status (FHR). FHR patients experience aggressive ...
Leonardo Ferreira, Ph.D., left, and graduate student Russell Cochrane envision CAR Tregs being useful in cancer, type 1 diabetes and organ transplants. A new paper from MUSC Hollings Cancer Center ...
Add Yahoo as a preferred source to see more of our stories on Google. Treg cells have been thrust into the limelight thanks to the Nobel Prize-winning work of a team of researchers from the U.S. and ...
GDAŃSK, Poland, March 10, 2026 (GLOBE NEWSWIRE) -- PolTREG SA (WSE: PTG), a pioneer and global leader in the development of therapies using T-regulatory lymphocytes (TREGs), announces that a ...
Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system’s faulty battle against the body’s own fabric. In type 1 diabetes, immune fighters attack beta cells in the ...
Researchers engineered immune cells that protect insulin-producing cell transplants, bringing scientists closer to a cure for type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results